These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 29395309

  • 21. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q, Li Y, Zhou J, Liu J, Qin J, Xing F, Zhang J, Cheng J.
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [Abstract] [Full Text] [Related]

  • 22. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
    Arabzadeh S, Hossein G, Salehi-Dulabi Z, Zarnani AH.
    Cell Mol Biol Lett; 2016 Jun; 21():9. PubMed ID: 28536612
    [Abstract] [Full Text] [Related]

  • 23. New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome.
    Raivola J, Dini A, Salokas K, Karvonen H, Niininen W, Piki E, Varjosalo M, Ungureanu D.
    Cell Mol Life Sci; 2022 May 04; 79(5):276. PubMed ID: 35504983
    [Abstract] [Full Text] [Related]

  • 24. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells.
    Saji T, Nishita M, Ogawa H, Doi T, Sakai Y, Maniwa Y, Minami Y.
    Genes Cells; 2018 Jul 04; 23(7):606-613. PubMed ID: 29845703
    [Abstract] [Full Text] [Related]

  • 25. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
    Xu J, Shi J, Tang W, Jiang P, Guo M, Zhang B, Ma G.
    J Cell Biochem; 2020 Oct 04; 121(10):4142-4153. PubMed ID: 32048761
    [Abstract] [Full Text] [Related]

  • 26. Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.
    Henry CE, Emmanuel C, Lambie N, Loo C, Kan B, Kennedy CJ, de Fazio A, Hacker NF, Ford CE.
    Transl Oncol; 2017 Jun 04; 10(3):346-356. PubMed ID: 28342318
    [Abstract] [Full Text] [Related]

  • 27. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
    Parker BA, Shatsky RA, Schwab RB, Wallace AM, I-SPY 2 Consortium, Wolf DM, Hirst GL, Brown-Swigart L, Esserman LJ, van 't Veer LJ, Ghia EM, Yau C, Kipps TJ.
    Breast Cancer Res Treat; 2023 Jun 04; 199(2):281-291. PubMed ID: 37029329
    [Abstract] [Full Text] [Related]

  • 28. Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma.
    Wang L, Yang D, Wang YH, Li X, Gao HM, Lv JY, Wang L, Xin SJ.
    Tumour Biol; 2016 May 04; 37(5):6085-90. PubMed ID: 26608372
    [Abstract] [Full Text] [Related]

  • 29. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM, Chen MW, Chen CA, Chien MH, Hua KT, Hsiao M, Kuo ML, Wei LH.
    Ann Surg Oncol; 2015 Dec 04; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [Abstract] [Full Text] [Related]

  • 30. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M, Nishita M, Fujii M, Minami Y.
    Int Rev Cell Mol Biol; 2015 Dec 04; 314():117-48. PubMed ID: 25619716
    [Abstract] [Full Text] [Related]

  • 31. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H, He Q, Gong G, Wang Y, Li J, Wang J, Zhu D, Wu X.
    Int J Oncol; 2016 Jan 04; 48(1):181-90. PubMed ID: 26575700
    [Abstract] [Full Text] [Related]

  • 32. Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling.
    Xiong S, Klausen C, Cheng JC, Zhu H, Leung PC.
    Oncotarget; 2015 Oct 13; 6(31):31659-73. PubMed ID: 26384307
    [Abstract] [Full Text] [Related]

  • 33. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
    Shih KK, Garg K, Levine DA, Kauff ND, Abu-Rustum NR, Soslow RA, Barakat RR.
    Gynecol Oncol; 2011 Oct 13; 123(1):88-94. PubMed ID: 21742371
    [Abstract] [Full Text] [Related]

  • 34. G-protein coupled receptor 64 (GPR64) acts as a tumor suppressor in endometrial cancer.
    Ahn JI, Yoo JY, Kim TH, Kim YI, Broaddus RR, Ahn JY, Lim JM, Jeong JW.
    BMC Cancer; 2019 Aug 14; 19(1):810. PubMed ID: 31412816
    [Abstract] [Full Text] [Related]

  • 35. Rap1GAP inhibits tumor progression in endometrial cancer.
    Tamate M, Tanaka R, Osogami H, Matsuura M, Satohisa S, Iwasaki M, Saito T.
    Biochem Biophys Res Commun; 2017 Apr 01; 485(2):476-483. PubMed ID: 28196746
    [Abstract] [Full Text] [Related]

  • 36. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
    Eskander RN, Ali S, Dellinger T, Lankes HA, Randall LM, Ramirez NC, Monk BJ, Walker JL, Eisenhauer E, Hoang BH.
    Int J Gynecol Cancer; 2016 Jan 01; 26(1):125-32. PubMed ID: 26397159
    [Abstract] [Full Text] [Related]

  • 37. ROR1-AS1 might promote in vivo and in vitro proliferation and invasion of cholangiocarcinoma cells.
    Li X, Sun Z, Wang L, Wang Q, Wang M, Guo J, Li H, Chen M, Cao G, Yu Y, Zhong H, Zou H, Ma K, Zhang B, Wang G, Feng Y.
    BMC Cancer; 2023 Sep 28; 23(1):912. PubMed ID: 37770853
    [Abstract] [Full Text] [Related]

  • 38. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
    Karvonen H, Perttilä R, Niininen W, Hautanen V, Barker H, Murumägi A, Heckman CA, Ungureanu D.
    Oncogene; 2019 Apr 28; 38(17):3288-3300. PubMed ID: 30631148
    [Abstract] [Full Text] [Related]

  • 39. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.
    O'Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, Li L, Herlyn M, Villanueva J, Liu Q, Yin X, Widura S, Nelson J, Ruiz N, Camilli TC, Indig FE, Flaherty KT, Wargo JA, Frederick DT, Cooper ZA, Nair S, Amaravadi RK, Schuchter LM, Karakousis GC, Xu W, Xu X, Weeraratna AT.
    Cancer Discov; 2013 Dec 28; 3(12):1378-93. PubMed ID: 24104062
    [Abstract] [Full Text] [Related]

  • 40. ROR2/Wnt5a Signaling Regulates Directional Cell Migration and Early Tumor Cell Invasion in Ovarian Cancer.
    Grither WR, Baker B, Morikis VA, Ilagan MXG, Fuh KC, Longmore GD.
    Mol Cancer Res; 2024 May 02; 22(5):495-507. PubMed ID: 38334461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.